Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [1]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PA5-63331 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- GYLTL1B Polyclonal Antibody
- Antibody type
- Polyclonal
- Antigen
- Recombinant full-length protein
- Description
- Immunogen sequence: ALAQLDEEDP CFEFRQQQLT VHRVHVTFLP HEPPPPRPHD VTLVAQ
- Concentration
- 0.2 mg/mL
Submitted references Acquired chemoresistance can lead to increased resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus.
Goad DW, Bressy C, Holbrook MC, Grdzelishvili VZ
Molecular therapy oncolytics 2022 Mar 17;24:59-76
Molecular therapy oncolytics 2022 Mar 17;24:59-76
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of GYLTL1B in Lane 1: Marker (kDa) 250, 130, 95, 72, 55, 36, 28, 17, 10; Lane 2: Human cell line RT-4; Lane 3: Human cell line U-251MG sp; Lane 4: Human plasma (IgG/HSA depleted); Lane 5: Human liver tissue. Samples were probed using a GYLTL1B Polyclonal Antibody (Product # PA5-63331).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunohistochemical staining of GYLTL1B in human bone marrow shows moderate cytoplasmic positivity in subset of hematopoietic cells. Samples were probed using a GYLTL1B Polyclonal Antibody (Product # PA5-63331).
